Abstract:Cardiovascular diseases, the leading life-threatening conditions, involve cardiac arrhythmia, coronary artery disease, myocardial infarction, heart failure, cardiomyopathy, and heart valve disease that are associated with the altered functioning of cation-chloride cotransporters. The decreased number of cation-chloride cotransporters leads to reduced reactivity to adrenergic stimulation. The KCC family is crucial for numerous physiological processes including cell proliferation and invasion, regulation of membrane trafficking, maintaining ionic and osmotic homeostasis, erythrocyte swelling, dendritic spine formation, maturation of postsynaptic GABAergic inhibition, and inhibitory/excitatory signaling in neural tracts. KCC2 maintains intracellular chlorine homeostasis and opposes β-adrenergic stimulation-induced Cl- influx to prevent arrhythmogenesis. KCC3-inactivated cardiac tissue shows increased vascular resistance, aortic distensibility, heart size and weight (i.e. hypertrophic cardiomyopathy). Due to KCC4's high affinity for K+, it plays a vital role in cardiac ischemia with increased extracellular K+. The NKCC and NCC families play a vital role in the regulation of saliva volume, establishing the potassium-rich endolymph in the cochlea, sodium uptake in astrocytes, inhibiting myogenic response in microcirculatory beds, regulation of smooth muscle tone in resistance vessels, and blood pressure. NKCC1 regulates chlorine homeostasis and knocking it out impairs cardiomyocyte depolarization and cardiac contractility as well as impairs depolarization and contractility of vascular smooth muscle rings in the aorta. The activation of NCC in vascular cells promotes the formation of the abdominal aortic aneurysm. This narrative review provides a deep insight into the structure and function of KCCs, NKCCs, and NCC in human physiology and cardiac pathobiology. Also, it provides cell-specific (21 cell types) and region-specific (6 regions) expression of KCC1, KCC2, KCC3, KCC4, NKCC1, NKCC2, and NCC in heart.

Potassium channel openers: therapeutic potential in cardiology and medicine.

Recent Development of Potassium Channel Modulators

Potassium-channel opener in cardioplegia may restore coronary endothelial function.

Current strategies for the discovery of K+ channel modulators.

From Basic Physiology to Clinical Applications

Potassium Channels: Structures, Diseases, and Modulators

Design, Synthesis and Biological Evaluation of Benzopyran Derivatives As KATP Channel Openers

Potassium Channel Opening Drugs Prevent Cardioplegic Solution-Induced Intracellular Ca2+ Loading in Cardiac Cells.

Studies on Benzopyran Derivatives As Potassium Channel Openers

Potassium Channel Blockers As Antiarrhythmic Agents

Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone

Molecular biology of K(+) channels and their role in cardiac arrhythmias.

Calcium-Activated Potassium Channels: Potential Target for Cardiovascular Diseases.

Functional Protection Against Cardiac Diseases Depends On Atp-Sensitive Potassium Channels

Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation.

Vascular large conductance calcium-activated potassium channels: Functional role and therapeutic potential

The network of cardiac KIR2.1: its function, cellular regulation, electrical signaling, diseases and new drug avenues

KCCs, NKCCs, and NCC: Potential targets for cardiovascular therapeutics? A comprehensive review of cell and region specific expression and function

Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5

The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

Alternative Targets for Modulators of Mitochondrial Potassium Channels